J&J to invest more than $2 billion in new manufacturing facility-March 2024-www.financetom.com

J&J to invest more than $2 billion in new manufacturing facility

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

J&J to invest more than $2 billion in new manufacturing facility

Oct 2, 2024 10:30 PM

Oct 1 (Reuters) - Johnson & Johnson ( JNJ ) said on

Tuesday it will invest more than $2 billion to build a new

manufacturing facility at Wilson, North Carolina.

Previous page： NuScale Power Names Alan Boeckmann Non-Executive Board Chairman Next page： Bank of America, US Soccer Federation Sign Long-Term Partnership

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

NuScale Power Names Alan Boeckmann Non-Executive Board Chairman

Jan 14, 2025

09:24 AM EST, 01/14/2025 (MT Newswires) -- NuScale Power ( SMR ) said Tuesday that it has named Alan Boeckmann non-executive chairman of the company's board of directors, effective Wednesday. Boeckmann, who has been a board member of NuScale Power ( SMR ) since 2020, is succeeding Jim Hackett, who will step down from the board to become lead independent...

Bank of America, US Soccer Federation Sign Long-Term Partnership

Jan 14, 2025

09:26 AM EST, 01/14/2025 (MT Newswires) -- Bank of America ( BAC ) and the US Soccer Federation said Tuesday that they have entered a long-term partnership making the bank the first official banking partner for the Federation's 27 national teams and a founding partner of its new training center in Atlanta. Financial terms for the partnership were not provided....

Eli Lilly Now Expects Q4 Revenue of About $13.5 billion; Roughly $400 Million Below Low-End of Recent Guidance

Jan 14, 2025

09:27 AM EST, 01/14/2025 (MT Newswires) -- Eli Lilly ( LLY ) said Tuesday its Q4 revenue is now expected to be about $13.5 billion, about $400 million below the low-end of the company's recently issued outlook. Analysts polled by FactSet expect $13.93 billion. The company plans to report its Q4 earnings and 2025 guidance Feb. 6. The company said...

Lilly forecasts weak sales of weight-loss drug in fourth quarter

Jan 14, 2025

Jan 14 (Reuters) - Eli Lilly ( LLY ) expects sales of popular weight-loss drug Zepbound and related diabetes treatment Mounjaro to miss Wall Street expectations in the fourth quarter, but forecast 2025 revenue largely above estimates. The company said on Tuesday it expects $3.5 billion in Mounjaro sales in the fourth quarter, and $1.9 billion for Zepbound. Analysts had...